FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to imidazole compounds of formula 
wherein the radical values A, X, R1, R2, R3 are presented in clause 1 of the patent claim.
EFFECT: there are disclosed pharmaceutical compositions of sail compounds for cytokine (eg TNFα or IL-1β) reduction.
16 cl, 107 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOACYLGLYCEROL LIPASE MODULATORS | 2019 |
|
RU2797323C2 |
| IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
| HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
| ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR INHIBITING NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPTAKE | 2005 |
|
RU2388751C2 |
| PESTICIDAL COMPOSITIONS | 2009 |
|
RU2513723C2 |
| PESTICIDE COMPOSITIONS AND METHODS RELATING THERETO | 2012 |
|
RU2596946C2 |
| ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2539591C2 |
| PHENOXYMETHYL HETEROCYCLIC COMPOUNDS | 2009 |
|
RU2531274C2 |
| IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS | 2013 |
|
RU2635917C2 |
| COMPOUNDS | 2016 |
|
RU2734877C2 |
